Bio-Therapeutics, Ltd. – Trademark Portfolio

Entity Type: 03

Bio-Therapeutics, Ltd. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 15 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include BIO-ZYME, THYMURIL, GUGULPLEX, and GARLITRIN 4000. The owner is based in Greenbay, WI.

825 Challenger Drive

Greenbay, WI 54311

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Bio-Therapeutics, Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (15 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

Frequently Asked Questions

How many trademarks does Bio-Therapeutics, Ltd. have?

Bio-Therapeutics, Ltd. has 16 U.S. trademarks filed with the USPTO. Of these, 4 registered, 3 abandoned, 9 cancelled.

What trademark classes does Bio-Therapeutics, Ltd. file in?

Bio-Therapeutics, Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Bio-Therapeutics, Ltd.'s most well-known trademarks?

Bio-Therapeutics, Ltd.'s registered trademark portfolio includes well-known marks such as BIO-ZYME, THYMURIL, GUGULPLEX, and GARLITRIN 4000. These are among 4 currently registered trademarks in the portfolio.

What is Bio-Therapeutics, Ltd.'s trademark registration success rate?

Bio-Therapeutics, Ltd. has a 25% trademark registration rate, with 4 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.